A prospective study on the use of warfarin in the United Arab Emirates

Abdulla Shehab, Asim Elnour, Abdishakur Abdulle, Abdul Kader Souid

Research output: Contribution to journalArticle

Abstract

Objectives: The aims of this study were to evaluate adherence of patients and medical staff to warfarin guidelines and assess clinical outcome and predictors of treatment failure. Methods: This cross-sectional survey involved out- and in-patient subjects receiving warfarin. Patient attentiveness, compliance, co-morbidities, complications, and international normalized ratio (INR) as well as adherence of medical staff to established warfarin treatment guidelines were recorded. Results: One-hundred-sixty patients were recruited (mean ± SD age = 54 ± 1.3 years; 46% males; 77% overweight/obese). Indications for warfarin were atrial fibrillation (35%), deep vein thrombosis (28%), prosthetic heart valve (20%) and stroke or dilated cardiomyopathy (12%). "Warfarin booklets" were made available to 25% of the patients, and ~80% of the recipients reported inadequate understanding of its content. INR was strictly monitored in 23% of the patients; ~70% never received Information Leaflets; ~88% were unaware of warning labels; and ~58% were unaware that over-thecounter medications may affect warfarin. Therapeutic INR (2.9 ± 0.2; 76 days) was achieved in 73%; 20% had high INR (3.7 ± 0.1; 18.6 days) and 7% had low INR (1.6 ± 0.1; 16.7 days). Of the patients with high INR, 2.5% had major bleeding events. Of the patients with low INR, 5% had thromboembolic events. Poor compliance and co-morbidities were associated with adverse events (p=0.01). Conclusions: Attentiveness and adherence to warfarin treatment and monitoring guidelines are suboptimal among patients and medical staff. Novel strategies are necessary to alert patients, pharmacists and physicians on the seriousness of warfarin treatment failure.

Original languageEnglish (US)
Pages (from-to)72-75
Number of pages4
JournalOpen Cardiovascular Medicine Journal
Volume6
Issue number1
DOIs
StatePublished - Jul 23 2012

Fingerprint

United Arab Emirates
Warfarin
International Normalized Ratio
Prospective Studies
Medical Staff
Guidelines
Patient Compliance
Treatment Failure
Morbidity
Pamphlets
Heart Valves
Dilated Cardiomyopathy
Pharmacists
Venous Thrombosis
Atrial Fibrillation
Outpatients
Therapeutics
Cross-Sectional Studies
Stroke
Hemorrhage

Keywords

  • Bleeding
  • International normalized ratio
  • Thromboembolism
  • United Arab Emirates
  • Warfarin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

A prospective study on the use of warfarin in the United Arab Emirates. / Shehab, Abdulla; Elnour, Asim; Abdulle, Abdishakur; Souid, Abdul Kader.

In: Open Cardiovascular Medicine Journal, Vol. 6, No. 1, 23.07.2012, p. 72-75.

Research output: Contribution to journalArticle

Shehab, Abdulla ; Elnour, Asim ; Abdulle, Abdishakur ; Souid, Abdul Kader. / A prospective study on the use of warfarin in the United Arab Emirates. In: Open Cardiovascular Medicine Journal. 2012 ; Vol. 6, No. 1. pp. 72-75.
@article{0679256dbf504625a71d47d457d260d5,
title = "A prospective study on the use of warfarin in the United Arab Emirates",
abstract = "Objectives: The aims of this study were to evaluate adherence of patients and medical staff to warfarin guidelines and assess clinical outcome and predictors of treatment failure. Methods: This cross-sectional survey involved out- and in-patient subjects receiving warfarin. Patient attentiveness, compliance, co-morbidities, complications, and international normalized ratio (INR) as well as adherence of medical staff to established warfarin treatment guidelines were recorded. Results: One-hundred-sixty patients were recruited (mean ± SD age = 54 ± 1.3 years; 46{\%} males; 77{\%} overweight/obese). Indications for warfarin were atrial fibrillation (35{\%}), deep vein thrombosis (28{\%}), prosthetic heart valve (20{\%}) and stroke or dilated cardiomyopathy (12{\%}). {"}Warfarin booklets{"} were made available to 25{\%} of the patients, and ~80{\%} of the recipients reported inadequate understanding of its content. INR was strictly monitored in 23{\%} of the patients; ~70{\%} never received Information Leaflets; ~88{\%} were unaware of warning labels; and ~58{\%} were unaware that over-thecounter medications may affect warfarin. Therapeutic INR (2.9 ± 0.2; 76 days) was achieved in 73{\%}; 20{\%} had high INR (3.7 ± 0.1; 18.6 days) and 7{\%} had low INR (1.6 ± 0.1; 16.7 days). Of the patients with high INR, 2.5{\%} had major bleeding events. Of the patients with low INR, 5{\%} had thromboembolic events. Poor compliance and co-morbidities were associated with adverse events (p=0.01). Conclusions: Attentiveness and adherence to warfarin treatment and monitoring guidelines are suboptimal among patients and medical staff. Novel strategies are necessary to alert patients, pharmacists and physicians on the seriousness of warfarin treatment failure.",
keywords = "Bleeding, International normalized ratio, Thromboembolism, United Arab Emirates, Warfarin",
author = "Abdulla Shehab and Asim Elnour and Abdishakur Abdulle and Souid, {Abdul Kader}",
year = "2012",
month = "7",
day = "23",
doi = "10.2174/1874192401206010072",
language = "English (US)",
volume = "6",
pages = "72--75",
journal = "Open Cardiovascular Medicine Journal",
issn = "1874-1924",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - A prospective study on the use of warfarin in the United Arab Emirates

AU - Shehab, Abdulla

AU - Elnour, Asim

AU - Abdulle, Abdishakur

AU - Souid, Abdul Kader

PY - 2012/7/23

Y1 - 2012/7/23

N2 - Objectives: The aims of this study were to evaluate adherence of patients and medical staff to warfarin guidelines and assess clinical outcome and predictors of treatment failure. Methods: This cross-sectional survey involved out- and in-patient subjects receiving warfarin. Patient attentiveness, compliance, co-morbidities, complications, and international normalized ratio (INR) as well as adherence of medical staff to established warfarin treatment guidelines were recorded. Results: One-hundred-sixty patients were recruited (mean ± SD age = 54 ± 1.3 years; 46% males; 77% overweight/obese). Indications for warfarin were atrial fibrillation (35%), deep vein thrombosis (28%), prosthetic heart valve (20%) and stroke or dilated cardiomyopathy (12%). "Warfarin booklets" were made available to 25% of the patients, and ~80% of the recipients reported inadequate understanding of its content. INR was strictly monitored in 23% of the patients; ~70% never received Information Leaflets; ~88% were unaware of warning labels; and ~58% were unaware that over-thecounter medications may affect warfarin. Therapeutic INR (2.9 ± 0.2; 76 days) was achieved in 73%; 20% had high INR (3.7 ± 0.1; 18.6 days) and 7% had low INR (1.6 ± 0.1; 16.7 days). Of the patients with high INR, 2.5% had major bleeding events. Of the patients with low INR, 5% had thromboembolic events. Poor compliance and co-morbidities were associated with adverse events (p=0.01). Conclusions: Attentiveness and adherence to warfarin treatment and monitoring guidelines are suboptimal among patients and medical staff. Novel strategies are necessary to alert patients, pharmacists and physicians on the seriousness of warfarin treatment failure.

AB - Objectives: The aims of this study were to evaluate adherence of patients and medical staff to warfarin guidelines and assess clinical outcome and predictors of treatment failure. Methods: This cross-sectional survey involved out- and in-patient subjects receiving warfarin. Patient attentiveness, compliance, co-morbidities, complications, and international normalized ratio (INR) as well as adherence of medical staff to established warfarin treatment guidelines were recorded. Results: One-hundred-sixty patients were recruited (mean ± SD age = 54 ± 1.3 years; 46% males; 77% overweight/obese). Indications for warfarin were atrial fibrillation (35%), deep vein thrombosis (28%), prosthetic heart valve (20%) and stroke or dilated cardiomyopathy (12%). "Warfarin booklets" were made available to 25% of the patients, and ~80% of the recipients reported inadequate understanding of its content. INR was strictly monitored in 23% of the patients; ~70% never received Information Leaflets; ~88% were unaware of warning labels; and ~58% were unaware that over-thecounter medications may affect warfarin. Therapeutic INR (2.9 ± 0.2; 76 days) was achieved in 73%; 20% had high INR (3.7 ± 0.1; 18.6 days) and 7% had low INR (1.6 ± 0.1; 16.7 days). Of the patients with high INR, 2.5% had major bleeding events. Of the patients with low INR, 5% had thromboembolic events. Poor compliance and co-morbidities were associated with adverse events (p=0.01). Conclusions: Attentiveness and adherence to warfarin treatment and monitoring guidelines are suboptimal among patients and medical staff. Novel strategies are necessary to alert patients, pharmacists and physicians on the seriousness of warfarin treatment failure.

KW - Bleeding

KW - International normalized ratio

KW - Thromboembolism

KW - United Arab Emirates

KW - Warfarin

UR - http://www.scopus.com/inward/record.url?scp=84863900694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863900694&partnerID=8YFLogxK

U2 - 10.2174/1874192401206010072

DO - 10.2174/1874192401206010072

M3 - Article

C2 - 22723807

AN - SCOPUS:84863900694

VL - 6

SP - 72

EP - 75

JO - Open Cardiovascular Medicine Journal

JF - Open Cardiovascular Medicine Journal

SN - 1874-1924

IS - 1

ER -